: Novo Nordisk, now Europe’s second-largest company by market cap, lifts outlook after 46% profit rise

Novo Nordisk, the Danish drugmaker that’s now the second-largest company in Europe by market capitalization, on Thursday reported a 46% rise in profit and lifted its outlook for the year.

Previous post The average Manhattan rent just hit a new record of $5,588 a month
Next post : SpaceX valuation rose by 12%, says fund where rocket launcher is top holding